Description: Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Empagliflozin Tablet 10mg from Vapi, Gujarat India. Empagliflozin Tablet a medication used for type 2 diabetes, lowers blood sugar by increasing glucose excretion in urine, and also reduces the risk of cardiovascular death and hospitalization for heart failure, and slows the progression of chronic kidney disease. Taj Pharma India is a trusted and leading manufacturer, exporter, and supplier of Empagliflozin 10mg Tablets, headquartered in Vapi, Gujarat. Specializing in premium-quality diabetes medications, Taj Pharma delivers safe and effective Empagliflozin tablets designed to manage type 2 diabetes by blocking glucose reabsorption in the kidneys. This process increases glucose excretion through urine, which helps lower blood sugar levels and supports better metabolic control. Our Empagliflozin 10mg Tablets not only aid in blood sugar regulation but also contribute to reducing the risk of cardiovascular complications, including heart failure and heart attack. Furthermore, the medication helps slow the progression of chronic kidney disease and supports weight loss by facilitating the loss of excess calories. It also offers the benefit of lowering blood pressure, making it a comprehensive therapy for diabetes patients. Taj Pharma’s manufacturing units are WHO-GMP certified and maintain stringent quality controls to ensure the highest product standards. With an extensive distribution network covering India, Africa, the Middle East, and Latin America, Taj Pharma also offers PCD Pharma Franchise opportunities for growth and market expansion. For reliable, affordable, and globally compliant Empagliflozin 10mg Tablets, Taj Pharma India is the preferred choice. Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Empagliflozin Tablet 10mg from Vapi, Gujarat India. Empagliflozin Tablet a medication used for type 2 diabetes, lowers blood sugar by increasing glucose excretion in urine, and also reduces the risk of cardiovascular death and hospitalization for heart failure, and slows the progression of chronic kidney disease.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 240 KB
